{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["CBD", "THC", "bioavailability", "therapeutic cannabinoids", "topical", "transdermal"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35214170", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "02", "Day": "18"}], "Language": ["eng"], "ELocationID": ["438", "10.3390/pharmaceutics14020438"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "14", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Feb", "Day": "18"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "The Transdermal Delivery of Therapeutic Cannabinoids.", "Abstract": {"AbstractText": ["Recently, several studies have indicated an increased interest in the scientific community regarding the application of <i>Cannabis sativa</i> plants, and their extracts, for medicinal purposes. This plant of enormous medicinal potential has been legalised in an increasing number of countries globally. Due to the recent changes in therapeutic and recreational legislation, cannabis and cannabinoids are now frequently permitted for use in clinical settings. However, with their highly lipophilic features and very low aqueous solubility, cannabinoids are prone to degradation, specifically in solution, as they are light-, temperature-, and auto-oxidation-sensitive. Thus, plant-derived cannabinoids have been developed for oral, nasal-inhalation, intranasal, mucosal (sublingual and buccal), transcutaneous (transdermal), local (topical), and parenteral deliveries. Among these administrations routes, topical and transdermal products usually have a higher bioavailability rate with a prolonged steady-state plasma concentration. Additionally, these administrations have the potential to eliminate the psychotropic impacts of the drug by its diffusion into a nonreactive, dead stratum corneum. This modality avoids oral administration and, thus, the first-pass metabolism, leading to constant cannabinoid plasma levels. This review article investigates the practicality of delivering therapeutic cannabinoids via skin in accordance with existing literature."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Pangenomics Lab, School of Science, RMIT University, Bundoora, VIC 3083, Australia."}], "LastName": "Mahmoudinoodezh", "ForeName": "Haleh", "Initials": "H"}, {"Identifier": ["0000-0002-2806-4300"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Pangenomics Lab, School of Science, RMIT University, Bundoora, VIC 3083, Australia."}], "LastName": "Telukutla", "ForeName": "Srinivasa Reddy", "Initials": "SR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Science, RMIT University, Melbourne, VIC 3000, Australia."}], "LastName": "Bhangu", "ForeName": "Sukhvir Kaur", "Initials": "SK"}, {"Identifier": ["0000-0002-9864-2794"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Pangenomics Lab, School of Science, RMIT University, Bundoora, VIC 3083, Australia."}], "LastName": "Bachari", "ForeName": "Ava", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Chemistry and Environmental Science, RMIT University, Melbourne, VIC 3000, Australia."}], "LastName": "Cavalieri", "ForeName": "Francesca", "Initials": "F"}, {"Identifier": ["0000-0002-7621-035X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Pangenomics Lab, School of Science, RMIT University, Bundoora, VIC 3083, Australia."}, {"Identifier": [], "Affiliation": "The UWA Institute of Agriculture, The University of Western Australia, Perth, WA 6009, Australia."}], "LastName": "Mantri", "ForeName": "Nitin", "Initials": "N"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Thomas B., El Sohly M.A. The Analytical Chemistry of Cannabis. Elsevier; Waltham, MA, USA: 2016. The botany of Cannabis sativa L. pp. 1\u201326."}, {"Citation": "Chandra S., Lata H., El Sohly M.A. Cannabis Sativa L.-Botany and Biotechnology. Springer; Berlin/Heidelberg, Germany: 2017."}, {"Citation": "Josefina F.-S.I., Robert V. Secondary metabolism in cannabis. Phytochem. Rev. 2008;3:615."}, {"Citation": "Wr\u00f3bel T., Dreger M., Wielgus K., S\u0142omski R. The application of plant in vitro cultures in cannabinoid production. Biotechnol. Lett. 2018;40:445\u2013454. doi: 10.1007/s10529-017-2492-1.", "ArticleIdList": ["10.1007/s10529-017-2492-1", "29249063"]}, {"Citation": "Pacula R.L., Smart R. Medical marijuana and marijuana legalization. Annu. Rev. Clin. Psychol. 2017;13:397\u2013419. doi: 10.1146/annurev-clinpsy-032816-045128.", "ArticleIdList": ["10.1146/annurev-clinpsy-032816-045128", "PMC6358421", "28482686"]}, {"Citation": "Roberto D. The Use of Endogenous and Synthetic Cannabinoids in Prostate Cancer Therapy. University of Toronto; Toronto, QC, Canada: 2018."}, {"Citation": "Kovalchuk O., Kovalchuk I. Cannabinoids as anticancer therapeutic agents. Cell Cycle. 2020;19:961\u2013989. doi: 10.1080/15384101.2020.1742952.", "ArticleIdList": ["10.1080/15384101.2020.1742952", "PMC7217364", "32249682"]}, {"Citation": "Marks D.H., Friedman A. The therapeutic potential of cannabinoids in dermatology. Skin Ther. Lett. 2018;23:1\u20135.", "ArticleIdList": ["30517778"]}, {"Citation": "Sarfaraz S., Adhami V.M., Syed D.N., Afaq F., Mukhtar H. Cannabinoids for cancer treatment: Progress and promise. Cancer Res. 2008;68:339\u2013342. doi: 10.1158/0008-5472.CAN-07-2785.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-2785", "18199524"]}, {"Citation": "Von Bayern A.M.P., Heathcote R.J.P., Rutz C., Kacelnik A. The role of experience in problem solving and innovative tool use in crows. Curr. Biol. 2009;19:1965\u20131968. doi: 10.1016/j.cub.2009.10.037.", "ArticleIdList": ["10.1016/j.cub.2009.10.037", "19913421"]}, {"Citation": "Russo E.B. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br. J. Pharmacol. 2011;163:1344\u20131364. doi: 10.1111/j.1476-5381.2011.01238.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01238.x", "PMC3165946", "21749363"]}, {"Citation": "Russo E.B., Marcu J. Cannabis pharmacology: The usual suspects and a few promising leads, in Advances in pharmacology. Adv. Pharmacol. 2017;80:67\u2013134.", "ArticleIdList": ["28826544"]}, {"Citation": "Carlini E.A. The good and the bad effects of (-) trans-delta-9-tetrahydrocannabinol (Delta 9-THC) on humans. Toxicon. 2004;44:461\u2013467. doi: 10.1016/j.toxicon.2004.05.009.", "ArticleIdList": ["10.1016/j.toxicon.2004.05.009", "15302527"]}, {"Citation": "Explore Chemistry  Quickly Find Chemical Information from Authoritative Sources.  [(accessed on 1 December 2021)]; Available online:  https://pubchem.ncbi.nlm.nih.gov."}, {"Citation": "Bruni N., Della Pepa C., Oliaro-Bosso S., Pessione E., Gastaldi D., Dosio F. Cannabinoid Delivery Systems for Pain and Inflammation Treatment. Molecules. 2018;23:2478. doi: 10.3390/molecules23102478.", "ArticleIdList": ["10.3390/molecules23102478", "PMC6222489", "30262735"]}, {"Citation": "Adelli G.R., Bhagav P., Taskar P., Hingorani T., Pettaway S., Gul W., El Sohly M.A., Repka M.A., Majumdar S. Development of a Delta9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug with Improved Ocular Bioavailability. Investig. Ophthalmol. Vis. Sci. 2017;58:2167\u20132179. doi: 10.1167/iovs.16-20757.", "ArticleIdList": ["10.1167/iovs.16-20757", "PMC5389743", "28399267"]}, {"Citation": "Wassmann C.S., H\u00f8jrup P., Klitgaard J.K. Cannabidiol is an effective helper compound in combination with bacitracin to kill Gram-positive bacteria. Sci. Rep. 2020;10:4112. doi: 10.1038/s41598-020-60952-0.", "ArticleIdList": ["10.1038/s41598-020-60952-0", "PMC7057955", "32139776"]}, {"Citation": "Velasco G., S\u00e1nchez C., Guzm\u00e1n M. Towards the use of cannabinoids as antitumour agents. Nat. Rev. Cancer. 2012;12:436\u2013444. doi: 10.1038/nrc3247.", "ArticleIdList": ["10.1038/nrc3247", "22555283"]}, {"Citation": "Palmieri B., Laurino C., Vadal\u00e0 M. A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars. Clin. Ter. 2019;170:e93\u2013e99.", "ArticleIdList": ["30993303"]}, {"Citation": "Gonzalez-Cuevas G., Martin-Fardon R., Kerr T.M., Stouffer D.G., Parsons L.H., Hammell D.C., Banks S.L., Stinchcomb A.L., Weiss F. Unique treatment potential of cannabidiol for the prevention of relapse to drug use: Preclinical proof of principle. Neuropsychopharmacology. 2018;43:2036\u20132045. doi: 10.1038/s41386-018-0050-8.", "ArticleIdList": ["10.1038/s41386-018-0050-8", "PMC6098033", "29686308"]}, {"Citation": "Koch N., Nassar N., Bachari A., Schanknecht E., Telukutla S., Zomer R., Piva T.J., Mantri N. Cannabidiol aqueous solubility enhancement: Comparison of three amorphous formulations strategies using different type of polymers. Int. J. Pharm. 2020;589:119812. doi: 10.1016/j.ijpharm.2020.119812.", "ArticleIdList": ["10.1016/j.ijpharm.2020.119812", "32882367"]}, {"Citation": "Singh K., Nassar N., Bachari A., Schanknecht E., Telukutla S., Zomer R., Piva T.J., Mantri N. The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer. Cancers. 2021;13:4107. doi: 10.3390/cancers13164107.", "ArticleIdList": ["10.3390/cancers13164107", "PMC8392233", "34439262"]}, {"Citation": "Bachari A., Piva T.J., Salami S.A., Jamshidi N., Mantri N. Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies. Int. J. Mol. Sci. 2020;21:6040. doi: 10.3390/ijms21176040.", "ArticleIdList": ["10.3390/ijms21176040", "PMC7503316", "32839414"]}, {"Citation": "Grotenhermen F. Cannabinoids for therapeutic use. Am. J. Drug Deliv. 2004;2:229\u2013240. doi: 10.2165/00137696-200402040-00003.", "ArticleIdList": ["10.2165/00137696-200402040-00003"]}, {"Citation": "Grotenhermen F., M\u00fcller-Vahl K. The therapeutic potential of cannabis and cannabinoids. Dtsch. Arztebl. Int. 2012;109:495\u2013501. doi: 10.3238/arztebl.2012.0495.", "ArticleIdList": ["10.3238/arztebl.2012.0495", "PMC3442177", "23008748"]}, {"Citation": "Iqbal J., Abbasi B.A., Ahmad R., Batool R., Mahmood T., Ali B., Khalil A.T., Kanwal S., Afzal Shah S., Alam M.M., et al. Potential phytochemicals in the fight against skin cancer: Current landscape and future perspectives. Biomed. Pharmacother. 2019;109:1381\u20131393. doi: 10.1016/j.biopha.2018.10.107.", "ArticleIdList": ["10.1016/j.biopha.2018.10.107", "30551389"]}, {"Citation": "Simmerman E., Qin X., Jack C.Y., Baban B. Cannabinoids as a potential new and novel treatment for melanoma: A pilot study in a murine model. J. Surg. Res. 2019;235:210\u2013215. doi: 10.1016/j.jss.2018.08.055.", "ArticleIdList": ["10.1016/j.jss.2018.08.055", "30691796"]}, {"Citation": "Malhotra P., Casari I., Falasca M. Therapeutic potential of cannabinoids in combination cancer therapy. Adv. Biol. Regul. 2021;79:100774. doi: 10.1016/j.jbior.2020.100774.", "ArticleIdList": ["10.1016/j.jbior.2020.100774", "33422460"]}, {"Citation": "B\u00edr\u00f3 T., T\u00f3th B.I., Hask\u00f3 G., Paus R., Pacher P. The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities. Trends Pharmacol. Sci. 2009;30:411\u2013420. doi: 10.1016/j.tips.2009.05.004.", "ArticleIdList": ["10.1016/j.tips.2009.05.004", "PMC2757311", "19608284"]}, {"Citation": "Lu Y., Anderson H.D. Cannabinoid signaling in health and disease. Can. J. Physiol. Pharmacol. 2017;95:311\u2013327. doi: 10.1139/cjpp-2016-0346.", "ArticleIdList": ["10.1139/cjpp-2016-0346", "28263083"]}, {"Citation": "Katz J., Costarides A.P. Facts vs. Fiction: The Role of Cannabinoids in the Treatment of Glaucoma. Curr. Ophthalmol. Rep. 2019;7:177\u2013181. doi: 10.1007/s40135-019-00214-z.", "ArticleIdList": ["10.1007/s40135-019-00214-z"]}, {"Citation": "McKallip R.J., Lombard C., Fisher M., Martin B.R., Ryu S., Grant S., Nagarkatti P.S., Nagarkatti M.J.B. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood. 2002;100:627\u2013634. doi: 10.1182/blood-2002-01-0098.", "ArticleIdList": ["10.1182/blood-2002-01-0098", "12091357"]}, {"Citation": "Ramer R., Heinemann K., Merkord J., Rohde H., Salamon A., Linnebacher M., Hinz B. COX-2 and PPAR-\u03b3 confer cannabidiol-induced apoptosis of human lung cancer cells. Mol. Cancer Ther. 2013;12:69\u201382. doi: 10.1158/1535-7163.MCT-12-0335.", "ArticleIdList": ["10.1158/1535-7163.MCT-12-0335", "23220503"]}, {"Citation": "Pertwee R.G., Howlett A., Abood M.E., Alexander S., Di Marzo V., Elphick M., Greasley P., Hansen H.S., Kunos G., Mackie K.J.P.r. International union of basic and clinical pharmacology. Lxxix. Cannabinoid receptors and their ligands: Beyond cb1 and cb2. Pharmacol. Rev. 2010;62:588\u2013631. doi: 10.1124/pr.110.003004.", "ArticleIdList": ["10.1124/pr.110.003004", "PMC2993256", "21079038"]}, {"Citation": "Wall M.E., Sadler B.M., Brine D., Taylor H., Perez-Reyes M. Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women. Clin. Pharmacol. Ther. 1983;34:352\u2013363. doi: 10.1038/clpt.1983.179.", "ArticleIdList": ["10.1038/clpt.1983.179", "6309462"]}, {"Citation": "Sawzdargo M., Nguyen T., Lee D.K., Lynch K.R., Cheng R., Heng H.H., George S.R., O\u2019Dowd B.F. Identification and cloning of three novel human G protein-coupled receptor genes GPR52, \u03a8GPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res. Mol. Brain Res. 1999;64:193\u2013198. doi: 10.1016/S0169-328X(98)00277-0.", "ArticleIdList": ["10.1016/S0169-328X(98)00277-0", "9931487"]}, {"Citation": "Venkatachalam K., Montell C. TRP channels. Annu. Rev. Biochem. 2007;76:387\u2013417. doi: 10.1146/annurev.biochem.75.103004.142819.", "ArticleIdList": ["10.1146/annurev.biochem.75.103004.142819", "PMC4196875", "17579562"]}, {"Citation": "Caterina M.J. TRP Channel Cannabinoid Receptors in Skin Sensation, Homeostasis, and Inflammation. ACS Chem. Neurosci. 2014;5:1107\u20131116. doi: 10.1021/cn5000919.", "ArticleIdList": ["10.1021/cn5000919", "PMC4240254", "24915599"]}, {"Citation": "An D., Peigneur S., Hendrickx L.A., Tytgat J. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. Int. J. Mol. Sci. 2020;21:5064. doi: 10.3390/ijms21145064.", "ArticleIdList": ["10.3390/ijms21145064", "PMC7404216", "32709050"]}, {"Citation": "Hammell D., Zhang L., Ma F., Abshire S., McIlwrath S., Stinchcomb A., Westlund K. Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur. J. Pain. 2016;20:936\u2013948. doi: 10.1002/ejp.818.", "ArticleIdList": ["10.1002/ejp.818", "PMC4851925", "26517407"]}, {"Citation": "Eubanks L.M., Rogers C.J., Beuscher, Koob G.F., Olson A.J., Dickerson T.J., Janda K.D. A Molecular Link between the Active Component of Marijuana and Alzheimer\u2019s Disease Pathology. Mol. Pharm. 2006;3:773\u2013777. doi: 10.1021/mp060066m.", "ArticleIdList": ["10.1021/mp060066m", "PMC2562334", "17140265"]}, {"Citation": "Velasco G., S\u00e1nchez C., Guzm\u00e1n M. Endocannabinoids and cancer. Endocannabinoids. 2015;231:449\u2013472.", "ArticleIdList": ["26408171"]}, {"Citation": "Velasco G., S\u00e1nchez C., Guzm\u00e1n M. Anticancer mechanisms of cannabinoids. Curr. Oncol. 2016;23:S23. doi: 10.3747/co.23.3080.", "ArticleIdList": ["10.3747/co.23.3080", "PMC4791144", "27022311"]}, {"Citation": "Eagleston L.R., Kalani N.K., Patel R.R., Flaten H.K., Dunnick C.A., Dellavalle R.P. Cannabinoids in dermatology: A scoping review. Dermatol. Online J. 2018;24:1. doi: 10.5070/D3246040706.", "ArticleIdList": ["10.5070/D3246040706", "30142706"]}, {"Citation": "Tijani A.O., Thakur D., Mishra D., Frempong D., Chukwunyere U.I., Puri A. Delivering therapeutic cannabinoids via skin: Current state and future perspectives. J. Control. Release. 2021;334:427\u2013451. doi: 10.1016/j.jconrel.2021.05.005.", "ArticleIdList": ["10.1016/j.jconrel.2021.05.005", "33964365"]}, {"Citation": "Pacher P., B\u00e1tkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 2006;58:389\u2013462. doi: 10.1124/pr.58.3.2.", "ArticleIdList": ["10.1124/pr.58.3.2", "PMC2241751", "16968947"]}, {"Citation": "Pucci M., Pirazzi V., Pasquariello N., Maccarrone M. Endocannabinoid signaling and epidermal differentiation. Eur. J. Dermatol. 2011;21((Suppl. S2)):29\u201334. doi: 10.1684/ejd.2011.1266.", "ArticleIdList": ["10.1684/ejd.2011.1266", "21628127"]}, {"Citation": "Sheriff T., Lin M.J., Dubin D., Khorasani H. The potential role of cannabinoids in dermatology. J. Dermatol. Treat. 2019;31:1\u20137. doi: 10.1080/09546634.2019.1675854.", "ArticleIdList": ["10.1080/09546634.2019.1675854", "31599175"]}, {"Citation": "Demuth D.G., Molleman A. Cannabinoid signalling. Life Sci. 2006;78:549\u2013563. doi: 10.1016/j.lfs.2005.05.055.", "ArticleIdList": ["10.1016/j.lfs.2005.05.055", "16109430"]}, {"Citation": "Glodde N., Jakobs M., Bald T., T\u00fcting T., Gaffal E. Differential role of cannabinoids in the pathogenesis of skin cancer. Life Sci. 2015;138:35\u201340. doi: 10.1016/j.lfs.2015.04.003.", "ArticleIdList": ["10.1016/j.lfs.2015.04.003", "25921771"]}, {"Citation": "Alkilani A.Z., McCrudden M.T., Donnelly R.F. Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7:438\u2013470. doi: 10.3390/pharmaceutics7040438.", "ArticleIdList": ["10.3390/pharmaceutics7040438", "PMC4695828", "26506371"]}, {"Citation": "Lodzki M., Godin B., Rakou L., Mechoulam R., Gallily R., Touitou E. Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. J. Control. Release. 2003;93:377\u2013387. doi: 10.1016/j.jconrel.2003.09.001.", "ArticleIdList": ["10.1016/j.jconrel.2003.09.001", "14644587"]}, {"Citation": "Lucas C.J., Galettis P., Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br. J. Clin. Pharm. 2018;84:2477\u20132482. doi: 10.1111/bcp.13710.", "ArticleIdList": ["10.1111/bcp.13710", "PMC6177698", "30001569"]}, {"Citation": "Hellriegel E.T., Bjornsson T.D., Hauck W.W. Interpatient variability in bioavailability is related to the extent of absorption: Implications for bioavailability and bioequivalence studies. Clin. Pharmacol. Ther. 1996;60:601\u2013607. doi: 10.1016/S0009-9236(96)90208-8.", "ArticleIdList": ["10.1016/S0009-9236(96)90208-8", "8988062"]}, {"Citation": "Millar S.A., Stone N.L., Yates A.S., O\u2019Sullivan S.E. A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. Front. Pharmacol. 2018;9:1365. doi: 10.3389/fphar.2018.01365.", "ArticleIdList": ["10.3389/fphar.2018.01365", "PMC6275223", "30534073"]}, {"Citation": "Grotenhermen F. Pharmacokinetics and Pharmacodynamics of Cannabinoids. Clin. Pharmacokinet. 2003;42:327\u2013360. doi: 10.2165/00003088-200342040-00003.", "ArticleIdList": ["10.2165/00003088-200342040-00003", "12648025"]}, {"Citation": "Pacifici R., Marchei E., Salvatore F., Guandalini L., Busard\u00f2 F.P., Pichini S. Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry. Clin. Chem. Lab. Med. (CCLM) 2018;56:94\u201396. doi: 10.1515/cclm-2017-0758.", "ArticleIdList": ["10.1515/cclm-2017-0758", "29176009"]}, {"Citation": "Mazzetti C., Ferri E., Pozzi M., Labra M. Quantification of the content of cannabinol in commercially available e-liquids and studies on their thermal and photo-stability. Sci. Rep. 2020;10:3697. doi: 10.1038/s41598-020-60477-6.", "ArticleIdList": ["10.1038/s41598-020-60477-6", "PMC7048723", "32111858"]}, {"Citation": "Ohlsson A., Lindgren J.E., Andersson S., Agurell S., Gillespie H., Hollister L.E. Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration. Biomed. Environ. Mass Spectrom. 1986;13:77\u201383. doi: 10.1002/bms.1200130206.", "ArticleIdList": ["10.1002/bms.1200130206", "2937482"]}, {"Citation": "Samara E., Bialer M., Mechoulam R. Pharmacokinetics of cannabidiol in dogs. Drug Metab. 1988;16:469\u2013472.", "ArticleIdList": ["2900742"]}, {"Citation": "Mechoulam R., Parker L.A., Gallily R. Cannabidiol: An overview of some pharmacological aspects. J. Clin. Pharmacol. 2002;42:11S\u201319S. doi: 10.1002/j.1552-4604.2002.tb05998.x.", "ArticleIdList": ["10.1002/j.1552-4604.2002.tb05998.x", "12412831"]}, {"Citation": "Merrick J., Lane B., Sebree T., Yaksh T., O\u2019Neill C., Banks S.L. Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric and Physiological Fluid. Cannabis Cannabinoid Res. 2016;1:102\u2013112. doi: 10.1089/can.2015.0004.", "ArticleIdList": ["10.1089/can.2015.0004", "PMC5576596", "28861485"]}, {"Citation": "Valiveti S., Hammell D.C., Earles D.C., Stinchcomb A. Transdermal delivery of the synthetic cannabinoid WIN 55,212-2: In vitro/in vivo correlation. Pharm. Res. 2004;21:1137\u20131145. doi: 10.1023/B:PHAM.0000032999.31948.2e.", "ArticleIdList": ["10.1023/B:PHAM.0000032999.31948.2e", "15290852"]}, {"Citation": "Ohlsson A., Lindgren J.E., Wahl\u00e9n A., Agurell S., Hollister L.E., Gillespie H.K. Single dose kinetics of deuterium labelled \u03941-tetrahydrocannabinol in heavy and light cannabis users. Biol. Mass Spectrom. 1982;9:6\u201310. doi: 10.1002/bms.1200090103.", "ArticleIdList": ["10.1002/bms.1200090103", "6277407"]}, {"Citation": "Agurell S., Leander K. Stability, transfer and absorption of cannabinoid constituents of cannabis (hashish) during smoking. Acta Pharm. Suec. 1971;8:391.", "ArticleIdList": ["5135173"]}, {"Citation": "Vandevenne M., Vandenbussche H., Verstraete A. Detection time of drugs of abuse in urine. Acta Clin. Belg. 2000;55:323\u2013333. doi: 10.1080/17843286.2000.11754319.", "ArticleIdList": ["10.1080/17843286.2000.11754319", "11484423"]}, {"Citation": "Widman M., Agurell S., Ehrnebo M., Jones G. Binding of (+)- and (minus)-delta-1-tetrahydrocannabinols and (minus)-7-hydroxy-delta-1-tetrahydrocannabinol to blood cells and plasma proteins in man. J. Pharm. Pharmacol. 1974;26:914\u2013916. doi: 10.1111/j.2042-7158.1974.tb09207.x.", "ArticleIdList": ["10.1111/j.2042-7158.1974.tb09207.x", "4156569"]}, {"Citation": "Ngwa W., Kumar R., Moreau M., Dabney R., Herman A. Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids. Front. Oncol. 2017;7:208. doi: 10.3389/fonc.2017.00208.", "ArticleIdList": ["10.3389/fonc.2017.00208", "PMC5609560", "28971063"]}, {"Citation": "Hollister L., Gillespie H., Ohlsson A., Lindgren J.E., Wahlen A., Agurell S. Do plasma concentrations of \u03b49-tetrahydrocannabinol reflect the degree of intoxication? J. Clin. Pharmacol. 1981;21:171S\u2013177S. doi: 10.1002/j.1552-4604.1981.tb02593.x.", "ArticleIdList": ["10.1002/j.1552-4604.1981.tb02593.x", "6271822"]}, {"Citation": "Stella B., Baratta F., Della Pepa C., Arpicco S., Gastaldi D., Dosio F.J.D. Cannabinoid formulations and delivery sys-tems: Current and future options to treat pain. Drugs. 2021;81:1513\u20131557. doi: 10.1007/s40265-021-01579-x.", "ArticleIdList": ["10.1007/s40265-021-01579-x", "PMC8417625", "34480749"]}, {"Citation": "Huestis M.A. Human cannabinoid pharmacokinetics. Chem. Biodivers. 2007;4:1770\u20131804. doi: 10.1002/cbdv.200790152.", "ArticleIdList": ["10.1002/cbdv.200790152", "PMC2689518", "17712819"]}, {"Citation": "Paudel K.S., Hammell D.C., Agu R.U., Valiveti S., Stinchcomb A.L. Cannabidiol bioavailability after nasal and transdermal application: Effect of permeation enhancers. Drug Dev. Ind. Pharm. 2010;36:1088\u20131097. doi: 10.3109/03639041003657295.", "ArticleIdList": ["10.3109/03639041003657295", "20545522"]}, {"Citation": "Bryson N., Sharma A. Nasal Cannabidiol Compositions. WO2017208072A2. WO Patent. 2017 December 7;"}, {"Citation": "Thomas B.J., Finnin B.C. The transdermal revolution. Drug Discov. Today. 2004;9:697\u2013703. doi: 10.1016/S1359-6446(04)03180-0.", "ArticleIdList": ["10.1016/S1359-6446(04)03180-0", "15341783"]}, {"Citation": "Stinchcomb A.L., Valiveti S., Hammell D.C., Ramsey D.R. Human skin permeation of delta8-tetrahydrocannabinol, cannabidiol and cannabinol. J. Pharm. Pharmacol. 2004;56:291\u2013297. doi: 10.1211/0022357022791.", "ArticleIdList": ["10.1211/0022357022791", "15025853"]}, {"Citation": "Yeroushalmi S., Nelson K., Sparks A., Friedman A. Perceptions and recommendation behaviors of dermatologists for medical cannabis: A pilot survey. Complement. Ther. Med. 2020;55:102552. doi: 10.1016/j.ctim.2020.102552.", "ArticleIdList": ["10.1016/j.ctim.2020.102552", "33220620"]}, {"Citation": "Hess C., Kr\u00e4mer M., Madea B. Topical application of THC containing products is not able to cause positive cannabinoid finding in blood or urine. Forensic Sci. Int. 2017;272:68\u201371. doi: 10.1016/j.forsciint.2017.01.008.", "ArticleIdList": ["10.1016/j.forsciint.2017.01.008", "28122323"]}, {"Citation": "Bolzinger M.-A., Brian\u00e7on S., Pelletier J., Chevalier Y. Penetration of drugs through skin, a complex rate-controlling membrane. Curr. Opin. Colloid Interface Sci. 2012;17:156\u2013165. doi: 10.1016/j.cocis.2012.02.001.", "ArticleIdList": ["10.1016/j.cocis.2012.02.001"]}, {"Citation": "Kong M., Chen X.G., Kweon D.K., Park H.J. Investigations on skin permeation of hyaluronic acid based nanoemulsion as transdermal carrier. Carbohydr. Polym. 2011;86:837\u2013843. doi: 10.1016/j.carbpol.2011.05.027.", "ArticleIdList": ["10.1016/j.carbpol.2011.05.027"]}, {"Citation": "Filon F.L., Mauro M., Adami G., Bovenzi M., Crosera M. Nanoparticles skin absorption: New aspects for a safety profile evaluation. Regul. Toxicol. Pharmacol. 2015;72:310\u2013322. doi: 10.1016/j.yrtph.2015.05.005.", "ArticleIdList": ["10.1016/j.yrtph.2015.05.005", "25979643"]}, {"Citation": "Larraneta E., Lutton R.E., Woolfson A.D., Donnelly R.F. Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development. Mater. Sci. Eng. 2016;104:1\u201332. doi: 10.1016/j.mser.2016.03.001.", "ArticleIdList": ["10.1016/j.mser.2016.03.001"]}, {"Citation": "Moser K., Kriwet K., Naik A., Kalia Y.N., Guy R.H. Passive skin penetration enhancement and its quantification in vitro. Eur. J. Pharm. Biopharm. 2001;52:103\u2013112. doi: 10.1016/S0939-6411(01)00166-7.", "ArticleIdList": ["10.1016/S0939-6411(01)00166-7", "11522474"]}, {"Citation": "Godin B., Touitou E. Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models. Adv. Drug Deliv. Rev. 2007;59:1152\u20131161. doi: 10.1016/j.addr.2007.07.004.", "ArticleIdList": ["10.1016/j.addr.2007.07.004", "17889400"]}, {"Citation": "Goyal R., Macri L.K., Kaplan H.M., Kohn J. Nanoparticles and nanofibers for topical drug delivery. J. Control. Release. 2016;240:77\u201392. doi: 10.1016/j.jconrel.2015.10.049.", "ArticleIdList": ["10.1016/j.jconrel.2015.10.049", "PMC4896846", "26518723"]}, {"Citation": "Prausnitz M.R., Langer R. Transdermal drug delivery. Nat. Biotechnol. 2008;26:1261\u20131268. doi: 10.1038/nbt.1504.", "ArticleIdList": ["10.1038/nbt.1504", "PMC2700785", "18997767"]}, {"Citation": "Di Meglio P., Perera G.K., Nestle F.O. The multitasking organ: Recent insights into skin immune function. Immunity. 2011;35:857\u2013869. doi: 10.1016/j.immuni.2011.12.003.", "ArticleIdList": ["10.1016/j.immuni.2011.12.003", "22195743"]}, {"Citation": "Ye Y., Wang C., Zhang X., Hu Q., Zhang Y., Liu Q., Wen D., Milligan J., Bellotti A., Huang L. A melanin-mediated cancer immunotherapy patch. Sci. Immunol. 2017;2:eaan5692. doi: 10.1126/sciimmunol.aan5692.", "ArticleIdList": ["10.1126/sciimmunol.aan5692", "29127106"]}, {"Citation": "Gu Z., Chen X. Towards Enhancing Skin Drug Delivery. Adv. Drug Deliv. Rev. 2018;127:1\u20132. doi: 10.1016/j.addr.2018.05.004.", "ArticleIdList": ["10.1016/j.addr.2018.05.004", "29903554"]}, {"Citation": "Al-Kassas R., Wen J., Cheng A.E.-M., Kim A.M.-J., Liu S.S.M., Yu J. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel. Carbohydr. Polym. 2016;153:176\u2013186. doi: 10.1016/j.carbpol.2016.06.096.", "ArticleIdList": ["10.1016/j.carbpol.2016.06.096", "27561485"]}, {"Citation": "Tanner T., Marks R.J.S.R. Technology, Delivering drugs by the transdermal route: Review and comment. Skin Res. Technol. 2008;14:249\u2013260. doi: 10.1111/j.1600-0846.2008.00316.x.", "ArticleIdList": ["10.1111/j.1600-0846.2008.00316.x", "19159369"]}, {"Citation": "Ngo H.V., Tran P.H., Lee B.-J., Tran T.T.J.N. Development of film-forming gel containing nanoparticles for transdermal drug delivery. Nanotechnology. 2019;30:415102. doi: 10.1088/1361-6528/ab2e29.", "ArticleIdList": ["10.1088/1361-6528/ab2e29", "31261146"]}, {"Citation": "Mahato R. Pharmaceutical Dosage Forms and Drug Delivery. Volume 6000. CRS press; Boca Raton, FL, USA: 2002. pp. 196\u2013197."}, {"Citation": "Thomas B., El Sohly M.J. The Analytical Chemistry of Cannabis: Quality Assessment, Assurance, and Regulation of Medicinal Marijuana and Cannabinoid Preparations. Volume 1. Elsevier; Amsterdam, The Netherlands: 2016. Chapter 3-medical cannabis formulations; pp. 43\u201361."}, {"Citation": "Cichewicz D.L., Welch S.P., Smith F.L. Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal \u03949-tetrahydrocannabinol. Eur. J. Pharmacol. 2005;525:74\u201382. doi: 10.1016/j.ejphar.2005.09.039.", "ArticleIdList": ["10.1016/j.ejphar.2005.09.039", "16288738"]}, {"Citation": "Wiedersberg S., Guy R.H. Transdermal drug delivery: 30+ years of war and still fighting! J. Control. Release. 2014;190:150\u2013156. doi: 10.1016/j.jconrel.2014.05.022.", "ArticleIdList": ["10.1016/j.jconrel.2014.05.022", "24852092"]}, {"Citation": "Dosio F., Arpicco S., Stella B., Fattal E. Hyaluronic acid for anticancer drug and nucleic acid delivery. Adv. Drug Deliv. Rev. 2016;97:204\u2013236. doi: 10.1016/j.addr.2015.11.011.", "ArticleIdList": ["10.1016/j.addr.2015.11.011", "26592477"]}, {"Citation": "Fairbairn J., Liebmann J., Rowan M.G. The stability of cannabis and its preparations on storage. J. Pharm. Pharmacol. Biochem. Behav. 1976;28:1\u20137. doi: 10.1111/j.2042-7158.1976.tb04014.x.", "ArticleIdList": ["10.1111/j.2042-7158.1976.tb04014.x", "6643"]}, {"Citation": "Adusumilli N.C., Hazuka E.L., Friedman A.J. Nanotechnology to deliver cannabinoids in dermatology. Precis. Nanomed. 2021;4:787\u2013794. doi: 10.33218/001c.24597.", "ArticleIdList": ["10.33218/001c.24597"]}, {"Citation": "Abrahamov A., Abrahamov A., Mechoulam R. An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 1995;56:2097\u20132102. doi: 10.1016/0024-3205(95)00194-B.", "ArticleIdList": ["10.1016/0024-3205(95)00194-B", "7776837"]}, {"Citation": "Razdan R.K. Structure-activity relationships in cannabinoids. Pharmacol. Rev. 1986;38:75\u2013149.", "ArticleIdList": ["3018800"]}, {"Citation": "Valiveti S., Hammell D.C., Earles D.C., Stinchcomb A.L. In vitro/in vivo correlation studies for transdermal \u03948-THC development. J. Pharm. Sci. 2004;93:1154\u20131164. doi: 10.1002/jps.20036.", "ArticleIdList": ["10.1002/jps.20036", "15067692"]}, {"Citation": "Liput D.J., Hammell D.C., Stinchcomb A.L., Nixon K. Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder. Pharmacol. Biochem. Behav. 2013;111:120\u2013127. doi: 10.1016/j.pbb.2013.08.013.", "ArticleIdList": ["10.1016/j.pbb.2013.08.013", "PMC4096899", "24012796"]}, {"Citation": "Touitou E., Fabin B., Dany S., Almog S. Transdermal delivery of tetrahydrocannabinol. Int. J. Pharm. 1988;43:9\u201315. doi: 10.1016/0378-5173(88)90052-X.", "ArticleIdList": ["10.1016/0378-5173(88)90052-X"]}, {"Citation": "Casiraghi A., Musazzi U.M., Centin G., Franz\u00e8 S., Minghetti P. Topical Administration of Cannabidiol: Influence of Vehicle-Related Aspects on Skin Permeation Process. Pharmaceuticals. 2020;13:337. doi: 10.3390/ph13110337.", "ArticleIdList": ["10.3390/ph13110337", "PMC7690861", "33114270"]}, {"Citation": "Park C., Zuo J., Somayaji V., Lee B.-J., L\u00f6benberg R. Development of a novel cannabinoid-loaded microemulsion towards an improved stability and transdermal delivery. Int. J. Pharm. 2021;604:120766. doi: 10.1016/j.ijpharm.2021.120766.", "ArticleIdList": ["10.1016/j.ijpharm.2021.120766", "34087415"]}, {"Citation": "Radwan-Prag\u0142owska J., Janus \u0141., Pi\u0105tkowski M., Sierakowska A., Szajna E., Mat\u00fdsek D., Bogda\u0142 D. Development of Stimuli-Responsive Chitosan/ZnO NPs Transdermal Systems for Controlled Cannabidiol Delivery. Polymers. 2021;13:211. doi: 10.3390/polym13020211.", "ArticleIdList": ["10.3390/polym13020211", "PMC7826855", "33435623"]}, {"Citation": "Marczewska J., Karwicka E., Drozd J., Anuszewskal E., Sliwinska A., Nosov A., Olszowska O. Assessment of cyto-toxic and genotoxic activity of alcohol extract of polyscias filicifolia shoot, leaf, cell biomass of suspension culture and saponin fraction. Acta Pol. Pharm. 2011;68:703\u2013710.", "ArticleIdList": ["21928715"]}, {"Citation": "Scheffer I.E., Hulihan J., Messenheimer J., Ali S., Keenan N., Griesser J., Gutterman D.L., Sebree T., Sadleir L.G. Safety and Tolerability of Transdermal Cannabidiol Gel in Children with Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial. JAMA Netw. Open. 2021;4:e2123930. doi: 10.1001/jamanetworkopen.2021.23930.", "ArticleIdList": ["10.1001/jamanetworkopen.2021.23930", "PMC8417764", "34477852"]}, {"Citation": "Momekova D., Danov Y., Momekov G., Ivanov E., Petrov P. Polysaccharide Cryogels Containing \u03b2-Cyclodextrin for the Delivery of Cannabidiol. Pharmaceutics. 2021;13:1774. doi: 10.3390/pharmaceutics13111774.", "ArticleIdList": ["10.3390/pharmaceutics13111774", "PMC8618209", "34834189"]}, {"Citation": "Momekova D., Ivanov E., Konstantinov S., Ublekov F., Petrov P.D. Nanocomposite Cryogel Carriers from 2-Hydroxyethyl Cellulose Network and Cannabidiol-Loaded Polymeric Micelles for Sustained Topical Delivery. Polymers. 2020;12:1172. doi: 10.3390/polym12051172.", "ArticleIdList": ["10.3390/polym12051172", "PMC7284876", "32443724"]}, {"Citation": "Pavithra P.S., Mehta A., Verma R.S. Synergistic interaction of \u03b2-caryophyllene with aromadendrene oxide 2 and phytol induces apoptosis on skin epidermoid cancer cells. Phytomedicine. 2018;47:121\u2013134. doi: 10.1016/j.phymed.2018.05.001.", "ArticleIdList": ["10.1016/j.phymed.2018.05.001", "30166097"]}, {"Citation": "Sharkawy A., Silva A.M., Rodrigues F., Barreiro F., Rodrigues A. Pickering emulsions stabilized with chitosan/collagen peptides nanoparticles as green topical delivery vehicles for cannabidiol (CBD) Colloids Surf. A Physicochem. Eng. Asp. 2021;631:127677. doi: 10.1016/j.colsurfa.2021.127677.", "ArticleIdList": ["10.1016/j.colsurfa.2021.127677"]}, {"Citation": "Vanti G., Grifoni L., Bergonzi M.C., Antiga E., Montefusco F., Caproni M., Bilia A.R. Development and optimisation of biopharmaceutical properties of a new microemulgel of cannabidiol for locally-acting dermatological delivery. Int. J. Pharm. 2021;607:121036. doi: 10.1016/j.ijpharm.2021.121036.", "ArticleIdList": ["10.1016/j.ijpharm.2021.121036", "34438005"]}, {"Citation": "Cairns E.A., Baldridge W.H., Kelly M.E.M. The endocannabinoid system as a therapeutic target in glaucoma. Neural Plast. 2016;2016:1\u201310. doi: 10.1155/2016/9364091.", "ArticleIdList": ["10.1155/2016/9364091", "PMC4737462", "26881140"]}, {"Citation": "Chelliah M.P., Zinn Z., Khuu P., Teng J.M. Self-initiated use of topical cannabidiol oil for epidermolysis bullosa. Pediatr. Dermatol. 2018;35:e224\u2013e227. doi: 10.1111/pde.13545.", "ArticleIdList": ["10.1111/pde.13545", "29786144"]}, {"Citation": "Maida V., Corban J. Topical medical cannabis: A new treatment for wound pain\u2014Three cases of Pyoderma Gangrenosum. J. Pain Symptom Manag. 2017;54:732\u2013736. doi: 10.1016/j.jpainsymman.2017.06.005.", "ArticleIdList": ["10.1016/j.jpainsymman.2017.06.005", "28818631"]}, {"Citation": "Bartner L.R., McGrath S., Rao S., Hyatt L.K., Wittenburg L.A. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Can. J. Vet. Res. 2018;82:178\u2013183.", "ArticleIdList": ["PMC6038832", "30026641"]}, {"Citation": "Scheuplein R.J., Blank I.H. Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J. Investig. Dermatol. 1973;60:286\u2013296. doi: 10.1111/1523-1747.ep12723090.", "ArticleIdList": ["10.1111/1523-1747.ep12723090", "4758734"]}, {"Citation": "Challapalli P.V., Stinchcomb A.L. In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation. Int. J. Pharm. 2002;241:329\u2013339. doi: 10.1016/S0378-5173(02)00262-4.", "ArticleIdList": ["10.1016/S0378-5173(02)00262-4", "12100860"]}, {"Citation": "Rabiei M., Kashanian S., Samavati S.S., Jamasb S., McInnes S.J.P. Nanomaterial and advanced technologies in transdermal drug delivery. J. Drug Target. 2020;28:356\u2013367. doi: 10.1080/1061186X.2019.1693579.", "ArticleIdList": ["10.1080/1061186X.2019.1693579", "31851847"]}, {"Citation": "Cristino L., Bisogno T., di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat. Rev. Neurol. 2019;16:1\u201321. doi: 10.1038/s41582-019-0284-z.", "ArticleIdList": ["10.1038/s41582-019-0284-z", "31831863"]}, {"Citation": "Mokoena D.R., George B.P., Abrahamse H. Enhancing breast cancer treatment using a combination of cannabidiol and gold nanoparticles for photodynamic therapy. Int. J. Mol. Sci. 2019;20:4771. doi: 10.3390/ijms20194771.", "ArticleIdList": ["10.3390/ijms20194771", "PMC6801525", "31561450"]}, {"Citation": "Gujjar M., Arbiser J., Coulon R., Banga A.K. Localized delivery of a lipophilic proteasome inhibitor into human skin for treatment of psoriasis. J. Drug Target. 2016;24:503\u2013507. doi: 10.3109/1061186X.2015.1087529.", "ArticleIdList": ["10.3109/1061186X.2015.1087529", "PMC5947949", "26391114"]}, {"Citation": "Premjeet S., Bilandi A., Sahil K., Akanksha M., Bihani S.G.L. Transdermal drug delivery system (patches), applications in present scenario. Int. J. Res. Pharm. Chem. 2011;1:1139\u20131151."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "17"}, {"Year": "2022", "Month": "1", "Day": "24"}, {"Year": "2022", "Month": "1", "Day": "26"}, {"Year": "2022", "Month": "2", "Day": "26", "Hour": "1", "Minute": "2"}, {"Year": "2022", "Month": "2", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "27", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "2", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["35214170", "PMC8876728", "10.3390/pharmaceutics14020438", "pharmaceutics14020438"]}}], "PubmedBookArticle": []}